Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong · Delayed Price · Currency is HKD 2.880
-0.070 (-2.37%)
Feb 11, 2026, 4:08 PM HKT
Venus Medtech (Hangzhou) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -642.59 | -714.31 | -703.75 | -1,058 | -373.64 | -181.99 |
Depreciation & Amortization | 57.35 | 66.47 | 76.67 | 108.36 | 48.76 | 36.01 |
Other Amortization | 44.64 | 44.64 | 48.11 | 3.99 | 2.87 | 1.7 |
Loss (Gain) From Sale of Assets | -3.39 | -3.53 | 1.27 | 0.13 | 0.15 | 0.56 |
Asset Writedown & Restructuring Costs | 187.99 | 187.99 | 248.78 | 420.23 | 236.15 | - |
Loss (Gain) From Sale of Investments | 95.75 | 81.01 | -21.29 | 0.19 | 0.66 | -1.31 |
Loss (Gain) on Equity Investments | 5.78 | 4.15 | 12.38 | 13.94 | 11.71 | -0.57 |
Stock-Based Compensation | - | - | - | - | - | 9 |
Provision & Write-off of Bad Debts | 20.97 | 21.44 | -2.21 | 21.97 | 3.05 | -0.05 |
Other Operating Activities | 19.91 | 26.29 | -152.55 | -98.26 | -239.77 | 39.47 |
Change in Accounts Receivable | 136.42 | 90.95 | 14.21 | -7.85 | -74.13 | -68.76 |
Change in Inventory | 7.55 | -0.59 | -26.18 | -13.68 | -29.18 | -37.63 |
Change in Accounts Payable | -9.25 | 4.85 | 24.73 | 0.38 | 3.46 | 3.84 |
Change in Unearned Revenue | 3.51 | -27.96 | 26.25 | -12.92 | 0.29 | -8.89 |
Change in Other Net Operating Assets | -95.54 | 242.35 | -156.44 | -108.26 | -47.28 | -28.41 |
Operating Cash Flow | -170.92 | 23.74 | -610.02 | -729.46 | -456.92 | -237.01 |
Capital Expenditures | 0.27 | -33.92 | -260.64 | -169.98 | -82.07 | -49.78 |
Sale of Property, Plant & Equipment | 14.02 | 14.62 | 2.91 | 9.41 | - | 0.03 |
Cash Acquisitions | - | - | - | -813.49 | -124.59 | -54.61 |
Divestitures | -0.48 | -0.48 | - | - | 22.5 | - |
Sale (Purchase) of Intangibles | -5.07 | -7.64 | -2.27 | -8.79 | -19.71 | -74.27 |
Sale (Purchase) of Real Estate | - | - | - | - | -43.39 | - |
Investment in Securities | -13.92 | - | -18.77 | -98.17 | -416.78 | -109.82 |
Other Investing Activities | 8 | 7.52 | -68.09 | 4.76 | 15 | - |
Investing Cash Flow | 2.82 | -19.9 | -346.86 | -1,072 | -653.04 | -297.94 |
Long-Term Debt Issued | - | 104.03 | 413.48 | 939.14 | - | - |
Total Debt Issued | 54.5 | 104.03 | 413.48 | 939.14 | - | - |
Long-Term Debt Repaid | - | -563.26 | -543.81 | -237.46 | -20.25 | -129.57 |
Total Debt Repaid | -215.32 | -563.26 | -543.81 | -237.46 | -20.25 | -129.57 |
Net Debt Issued (Repaid) | -160.82 | -459.23 | -130.34 | 701.68 | -20.25 | -129.57 |
Issuance of Common Stock | - | - | - | - | 1,206 | 1,047 |
Repurchase of Common Stock | - | - | - | - | -72.55 | - |
Other Financing Activities | 124.89 | -28.11 | -43.65 | -66.55 | 278.31 | 10.37 |
Financing Cash Flow | -35.93 | -487.34 | -173.99 | 635.14 | 1,391 | 927.75 |
Foreign Exchange Rate Adjustments | -2.82 | 7.14 | 25.83 | 90.81 | -34.4 | -97.89 |
Net Cash Flow | -206.85 | -476.36 | -1,105 | -1,076 | 247.04 | 294.92 |
Free Cash Flow | -170.65 | -10.18 | -870.66 | -899.44 | -538.99 | -286.79 |
Free Cash Flow Margin | -39.94% | -2.16% | -177.19% | -221.28% | -129.61% | -103.89% |
Free Cash Flow Per Share | -0.39 | -0.02 | -1.99 | -2.05 | -1.23 | -0.70 |
Cash Interest Paid | 25.61 | 28.61 | 61.69 | 43.81 | 1.96 | 2.33 |
Cash Income Tax Paid | 1.69 | 0.95 | 3.44 | 3.07 | 8.65 | 5.47 |
Levered Free Cash Flow | -55.42 | 155.46 | -717.63 | -559.42 | -268.15 | -396.39 |
Unlevered Free Cash Flow | -46.66 | 165.86 | -678.43 | -531.53 | -266.96 | -395.04 |
Change in Working Capital | 42.69 | 309.59 | -117.43 | -142.32 | -146.85 | -139.83 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.